Biologic therapies for low-grade lymphomas.
Parkinson
D R
DR
Investigational Drug Branch, National Cancer Institute, Bethesda, MD 20892.
Sznol
M
M
Cheson
B D
BD
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015847:Interleukin-4 / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*
D000477:Alkylating Agents; D000911:Antibodies, Monoclonal; D016898:Interferon-alpha; D007376:Interleukin-2; D015847:Interleukin-4